Literature DB >> 10826128

Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

M S Roberts1, Y G Anissimov.   

Abstract

The conventional convection-dispersion (also called axial dispersion) model is widely used to interrelate hepatic availability (F) and clearance (Cl) with the morphology and physiology of the liver and to predict effects such as changes in liver blood flow on F and Cl. An extended form of the convection-dispersion model has been developed to adequately describe the outflow concentration-time profiles for vascular markers at both short and long times after bolus injections into perfused livers. The model, based on flux concentration and a convolution of catheters and large vessels, assumes that solute elimination in hepatocytes follows either fast distribution into or radial diffusion in hepatocytes. The model includes a secondary vascular compartment, postulated to be interconnecting sinusoids. Analysis of the mean hepatic transit time (MTT) and normalized variance (CV2) of solutes with extraction showed that the discrepancy between the predictions of MTT and CV2 for the extended and unweighted conventional convection-dispersion models decreases as hepatic extraction increases. A correspondence of more than 95% in F and Cl exists for all solute extractions. In addition, the analysis showed that the outflow concentration-time profiles for both the extended and conventional models are essentially identical irrespective of the magnitude of rate constants representing permeability, volume, and clearance parameters, providing that there is significant hepatic extraction. In conclusion, the application of a newly developed extended convection-dispersion model has shown that the unweighted conventional convection-dispersion model can be used to describe the disposition of extracted solutes and, in particular, to estimate hepatic availability and clearance in both experimental and clinical situations.

Entities:  

Mesh:

Year:  1999        PMID: 10826128     DOI: 10.1023/a:1020992421184

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  44 in total

1.  Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.

Authors:  G D Mellick; Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

2.  Interconnected-tubes model of hepatic elimination.

Authors:  Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Theor Biol       Date:  1997-09-07       Impact factor: 2.691

3.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

4.  On the relation between extended forms of the sinusoidal perfusion and of the convection-dispersion models of hepatic elimination.

Authors:  L Bass; M S Roberts; P J Robinson
Journal:  J Theor Biol       Date:  1987-06-21       Impact factor: 2.691

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Hepatic elimination--dispersion model.

Authors:  M S Roberts; M Rowland
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

7.  Sex differences in multiple steps in hepatic transport of palmitate support a balanced uptake mechanism.

Authors:  B A Luxon; D C Holly; M T Milliano; R A Weisiger
Journal:  Am J Physiol       Date:  1998-01

8.  Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.

Authors:  W Geng; A J Schwab; T Horie; C A Goresky; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

9.  Hepatic structure-pharmacokinetic relationships: the hepatic disposition and metabolite kinetics of a homologous series of O-acyl derivatives of salicylic acid.

Authors:  D Y Hung; G D Mellick; Y G Anissimov; M Weiss; M S Roberts
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

10.  Role of ligandin in transfer of bilirubin from plasma into liver.

Authors:  A W Wolkoff; C A Goresky; J Sellin; Z Gatmaitan; I M Arias
Journal:  Am J Physiol       Date:  1979-06
View more
  9 in total

1.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

4.  Physiologically based synthetic models of hepatic disposition.

Authors:  C Anthony Hunt; Glen E P Ropella; Li Yan; Daniel Y Hung; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-19       Impact factor: 2.745

5.  Modeling and simulation of hepatic drug disposition using a physiologically based, multi-agent in silico liver.

Authors:  Li Yan; Glen E P Ropella; Sunwoo Park; Michael S Roberts; C Anthony Hunt
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

6.  Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of long-chain fatty acids bound to albumin.

Authors:  G Rajaraman; M S Roberts; D Hung; G Q Wang; F J Burczynski
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

7.  Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application.

Authors:  Yuri Dancik; Yuri G Anissimov; Owen G Jepps; Michael S Roberts
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

8.  Cloud computing and validation of expandable in silico livers.

Authors:  Glen E P Ropella; C Anthony Hunt
Journal:  BMC Syst Biol       Date:  2010-12-03

9.  Physiologically based structure of mean residence time.

Authors:  Mária Durišová
Journal:  ScientificWorldJournal       Date:  2012-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.